(Q46944983)

26 December 2017

title

The cystic fibrosis lung microbiome (English)

1 reference

26 December 2017

0 references

0 references

Michael G Surette

1

1 reference

26 December 2017

publication date

1 January 2014

1 reference

26 December 2017

Proceedings of the American Thoracic Society

published in

1 reference

26 December 2017

volume

11 Suppl 1

1 reference

26 December 2017

page(s)

S61-5

1 reference

26 December 2017

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

cites work

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

The changing microbial epidemiology in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Lung infections associated with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Cystic fibrosis: what to expect now in the early adult years

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

The interplay between the intestinal microbiota and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Human microbiome in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

The colonic microbiota in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Bacterial biogeography of the human digestive tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

The microbiome of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Airway surface dehydration in cystic fibrosis: pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

The cystic fibrosis airway microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Cystic fibrosis: a polymicrobial infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Spatial distribution of microbial communities in the cystic fibrosis lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Case studies of the spatial heterogeneity of DNA viruses in the cystic fibrosis lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Impact of enhanced Staphylococcus DNA extraction on microbial community measures in cystic fibrosis sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Decade-long bacterial community dynamics in cystic fibrosis airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

The Streptococcus milleri population of a cystic fibrosis clinic reveals patient specificity and intraspecies diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

The genus Prevotella in cystic fibrosis airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Culture enriched molecular profiling of the cystic fibrosis airway microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

The cystic fibrosis airway microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201306-159MG

10.1513/ANNALSATS.201306-159MG

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017